Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Genotype 1B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Study completedNCT01995266
What this trial is testing

Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 218
Testing effectiveness (Phase 2)Study completedNCT02268864
What this trial is testing

Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants

Who this might be right for
Hepatitis C, Chronic
Janssen-Cilag International NV 106
Post-approval studies (Phase 4)Study completedNCT02480686
What this trial is testing

Neutrino Regimen for Treatment-experienced HCV GT1 Patients

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 32
Testing effectiveness (Phase 2)UnknownNCT01835938
What this trial is testing

Clinical Investigation of Erlotinib as an HCV Entry Inhibitor

Who this might be right for
Chronic Hepatitis C InfectionHCV Genotype 1b
University Hospital, Strasbourg, France 12
Testing effectiveness (Phase 2)Study completedNCT01938625
What this trial is testing

Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Who this might be right for
Hepatitis C, Chronic
Janssen R&D Ireland 35
Large-scale testing (Phase 3)UnknownNCT03222167
What this trial is testing

Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b

Who this might be right for
Chronic Hepatitis C Genotype 1BMetabolic SyndromeFibrosis, Liver+1 more
Institute Of Cardiology & Internal Diseases, Kazakhstan 60
Large-scale testing (Phase 3)Study completedNCT02023099
What this trial is testing

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 363
Not applicableStudy completedNCT02727933
What this trial is testing

Postmarketing Surveillance of the Safety and Effectiveness of Daclatasvir and Asunaprevir for the Treatment of Chronic HCV Genotype 1B Infection in the Routine Clinical Practice in Korea

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 1,941
Post-approval studies (Phase 4)Study completedNCT00680173
What this trial is testing

Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients

Who this might be right for
Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 30
Early research (Phase 1)Study completedNCT01247194
What this trial is testing

A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Presidio Pharmaceuticals, Inc. 24
Post-approval studies (Phase 4)Ended earlyNCT03003338
What this trial is testing

MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV

Who this might be right for
Hepatitis C, Chronic
Hannover Medical School 5
Large-scale testing (Phase 3)Study completedNCT02473211
What this trial is testing

SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 106
Testing effectiveness (Phase 2)Study completedNCT01830127
What this trial is testing

BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 35
Testing effectiveness (Phase 2)WithdrawnNCT02932293
What this trial is testing

Triple Combination DAAs for Treating HCV GT1b Subjects

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre
Testing effectiveness (Phase 2)WithdrawnNCT02397395
What this trial is testing

An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.

Who this might be right for
Renal ImpairmentEnd-stage Renal Disease
Janssen R&D Ireland
Large-scale testing (Phase 3)WithdrawnNCT02806362
What this trial is testing

Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)

Who this might be right for
Chronic Hepatitis C Virus
AbbVie
Large-scale testing (Phase 3)Study completedNCT01718145
What this trial is testing

A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects

Who this might be right for
Hepatitis C Virus Infection
Bristol-Myers Squibb 258